ArticleCell journal2019

Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial.

Seyed Massood Nabavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.